The EHA Research Roadmap: Blood Coagulation and Hemostatic Disorders

Authors: Eichinger, S; Morange, PE.; Cattaneo, M; Fretigny, M; Rauch, A; van Hylckama V, Astrid; T, David-A; Ruf, W; Levi, M; Páramo, JA.; van der Poll, T; Kyrle, PA.; Garagiola, I; Peyvandi, F.

Affiliations: Department of Medicine I, Division of Hematology and Hemostasis, Medical University of Vienna, Austria. C2VN, INRAE, INSERM Aix-Marseille University, France. Università degli Studi di Milano, Italy. Hospices Civils de Lyon, France. University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, France. Department of Clinical Epidemiology, Leiden University Medical Center, The Netherlands. University Bordeaux, INSERM UMR 1219, Bordeaux Population Health Research Center, France. Center for Thrombosis and Hemostasis, Johannes Gutenberg University Medical Center Mainz, Mainz, Germany. Amsterdam University Medical Centers, Department of Vascular Medicine, University of Amsterdam, The Netherlands. Department of Medicine, University College London Hospitals, United Kingdom. Clínica Universidad de Navarra, Pamplona, Spain. Amsterdam University Medical Centers, Division of Infectious Diseases & Center of Experimental Molecular Medicine, University of Amsterdam, The Netherlands. Fondazione IRCCS Ca’Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Italy.

Publication: HemaSphere. 2021. 5. e643 ; September 2021

Abstract: In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research (1) aiming to highlight achievements in the diagnostics and treatment of blood disorders, and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. Each section was coordinated by 1-2 section editors who were leading international experts in the field. In the 5 years that have followed, advances in the field of hematology have been plentiful. As such, EHA is pleased to present an updated Research Roadmap, now including 11 sections, each of which will be published separately. The updated EHA Research Roadmap identifies the most urgent priorities in hematology research and clinical science, therefore supporting a more informed, focused, and ideally funded future for European hematology research. The 11 EHA Research Roadmap sections include Normal Hematopoiesis; Malignant Lymphoid Diseases; Malignant Myeloid Diseases; Anemias and Related Diseases; Platelet Disorders; Blood Coagulation and Hemostatic Disorders; Transfusion Medicine; Infections in Hematology; Hematopoietic Stem Cell Transplantation; CAR-T and Other Cell-based Immune Therapies; and Gene Therapy.